 Lexaria Bioscience Corp CSE:LXX OTCMKTS:LXRP has updated investors on the progress of assessing its DehydraTECH CBD technology in treating high blood pressure, noting that all five of its planned studies for this year are now underway. Three human clinical trials and two animal research studies are in progress. 